baber/WOPTO huggingface dataset:
Patent DE-69330508-T2 (DE)
Inventor: SHABER STEVEN HOWARD
IPC: C07D249/12
Filed: 1993-06-16
Granted: 2002-09-12
Abstract: Fungicidal and herbicidal compounds are disclosed having the formula   <CHEM>  wherein X is (C6-C10)aryl optionally substituted with up to three substituents which are independently hydroxy, halo, nitro, trihalomethyl, cyano, (C1-C4)alkyl, (C1-C4)alkoxy, (C1-C4)alkylthio, (C1-C4)alkylsulfinyl, (C1-C4)alkylsulfonyl, (C1-C4)alkoxy(C1-C4)alkoxy, (C1-C4)alkylcarbonyl, (C2-C8)alkenyl, (C2-C4)alkenyloxy, (C2-C8)alkynyl, (C2-C8)alkynyloxy, phenyl, phenyl monosubstituted with halo, alkyl or alkoxy, phenoxy or phenoxy monosubstituted with halo, alkyl or alkoxy; or a 5 or 6 membered heterocyclic ring having up to three different hetero atoms selected from nitrogen, oxygen and sulphur and optionally substituted with up to two substituents which are independently (C6-C10)aryl or halo; or X is substituted with -O- at the 2-position to complete a lactone with W; Q is 1-(1,2,4-triazolyl) or 4-(1,2,4-triazolyl) optionally substituted with up to two substituents which are independently halo, (C1-C4)alkyl, nitro, cyano, mercapto or (C1-C5)alkylmercapto; Z is cyano, alkoxycarbonyl, (C1-C12)alkyl, halo(C1-C12)alkyl, (C2-C8)alkenyl, halo(C2-C8)alkenyl, (C2-C8)alkynyl, (C3-C8)cycloalkyl, (C5-C8)cycloalkenyl, (C3-C8)cycloalkylalkyl, (C6-C10)aryl, (C7-C11)aralkyl, heterocyclyl or heterocyclyl(C1-C4)alkyl, provided X and Z are not heterocyclyl at the same time; W is -OK, -OR, -OR'OR'', -OR'Y, -OR'COOR'', -OR'OCOR'', -NB2, morpholinyl, piperidinyl, piperidinyl substituted with (C1-C4)alkyl, or an oxygen completing a lactone when joined with X; B is hydrogen, (C1-C12)alkyl, hydroxy(C3-C5)alkyl or (C2-C6)alkenyl; R is (C1-C12)alkyl, X, (C3-C8)alkenyl, (C3-C8)alkynyl, (C3-C8)cycloalkyl(C1-C5)alkyl, cyano(C1-C5)alkyl, hydroxy(C2-C4)alkyl or epoxy(C1-C5)alkyl, all of which are optionally halogenated, or is hydrogen; provided that when Z is phenyl, W is not NB2 and when Z is methyl, W is not methoxy;     R' is (-CH(CH3)-)p(-CH2-)n or (-CH2-)qCH=CH(-CH2-)m;     n is an integer from 0 to 6;     p is 0 or 1, provided n and p are not both 0;     q and m are each independently integers from 0 to 3; R'' is (C1-C6)alkyl, X, Y-(C1-C4)alkyl or (C1-C2)trialkylsilyl(C1-C4)alkyl, all optionally halogenated, or hydrogen; and Y is phenyl, naphthyl, piperidinyl, triazolyl, pyrazinyl, phthalimido, morpholinyl, pyridyl, thienyl, furyl or (C3-C8)cycloalkyl, all of which may be optionally substituted with the substituents defined for X; and the agronomically acceptable enantiomorphs, acid addition salts and metal salt complexes thereof. Processes for making the compounds are also disclosed.
Patent DE-69426984-T2 (DE)
Inventor: AL-RAZZAK A
IPC: A61K31/425
Filed: 1994-09-09
Granted: 2001-11-22
Abstract: A solid pharmaceutical composition is disclosed which comprises a pharmaceutically acceptable adsorbent or a mixture of pharmaceutically acceptable adsorbents to which is adsorbed a mixture of (1) a pharmaceutically acceptable organic solvent or a mixture of pharmaceutically acceptable organic solvents, (2) an HIV protease inhibiting compound and (3) one or more pharmaceutically acceptable acids. The solid composition can optionally be encapsulated in a hard gelatin capsule.
Patent DE-69431878-T2 (DE)
Inventor: LUCAS JAMES
IPC: E04H9/10
Filed: 1994-08-18
Granted: 2003-08-28
Abstract: PCT No. PCT/AU94/00484 Sec. 371 Date Jun. 15, 1995 Sec. 102(e) Date Jun. 15, 1995 PCT Filed Aug. 18, 1994 PCT Pub. No. WO95/05513 PCT Pub. Date Feb. 23, 1995An explosion resistant structure comprises arcuate interlocking cold roll formed profiled steel panels (59) over which an outer (51) of steel reinforced concrete is formed. The outer concrete skin (51) is formed integrally with a steel reinforced concrete base (60) in turn formed integrally with a steel reinforced concrete floor. Planar front and rear walls (54, 63) are formed by planar cold roll formed profiled interlocking steel panels of a similar configuration to the arcuate roof panels and a steel reinforced concrete skin is also formed over the planar steel panels. The profiled steel panels (70) are of a substantially U-shaped cross section, the upper portions (72) of the side walls (76) being interlocked and the entire side wall portions and interlocked portions are encapsulated in the steel reinforced concrete layer to form a substantially continuous steel skin over the inner surface of the structure.
Patent DE-69432869-T2 (DE)
Inventor: STAVRIDI MARIGO
IPC: G01N33/66
Filed: 1994-04-01
Granted: 2004-05-13
Abstract: A glucose monitor, and related method, determines the concentration of glucose in a sample by monitoring fluorescent light produced directly by any glucose present in the sample. The glucose monitor illuminates the sample with ultraviolet excitation light that induces any glucose present in the sample to fluoresce, with the fluorescent light being monitored and processed to determine the concentration of glucose in the sample. A sensor monitors the return light, which includes fluorescent light produced by any glucose in the sample, and generates first and second electrical signals indicative of the intensity of light in two wavelength bands. One wavelength band includes a characteristic spectral peak of glucose fluorescence, and the other wavelength band is a reference band having known spectral characteristics. A processor then processes the first and second electrical signals to determine the concentration of glucose in the sample. A fiber-optic waveguide is used to guide the excitation light from the laser light source to the sample and the return light from the sample to the sensor. The fiber-optic waveguide is housed in a catheter or probe that is adapted to monitor the concentration of glucose percutaneously in the oral cavity tissues of a person's mouth such as the gums. <IMAGE>
Patent DE-69433333-T2 (DE)
Inventor: WIRKUS RANDOLF ANDREW
IPC: E04G21/18
Filed: 1994-08-15
Granted: 2004-09-09
Abstract: A glass brick wall (1) comprising a plurality of generally rectangular glass bricks (2) layed in horizontal runs between spaced elongated vertically extending support frame members (3), the wall having horizontally extending elongated separation strips (4) between adjacent horizontal runs, characterised in that, the vertical support frame members (5) present a face incorporating vertically spaced apertures (9) receiving said separation strips (4). <IMAGE>
Patent DE-69433595-T2 (DE)
Inventor: KOBAYASHI TOMOYUKI
IPC: B29C44/22
Filed: 1994-12-14
Granted: 2005-02-10
Abstract: An object of the present invention is to provide a foam molding which is light, excellent in bending strength, and excellent in balance between compressive strength and compression permanent strain, being a foam in which thermoplastic resin high expanded foams whose overall outer surfaces are covered with thermoplastic resin low-expanded-foam thin layers are thermally fused with each other through the aforementioned low-expanded-foam thin layers. <IMAGE>
Patent DE-69501080-T2 (DE)
Inventor: BASTART JEAN-PIERRE
IPC: C07D305/14
Filed: 1995-04-03
Granted: 1998-04-02
Abstract: PCT No. PCT/FR95/00419 Sec. 371 Date Oct. 3, 1996 Sec. 102(e) Date Oct. 3, 1996 PCT Filed Apr. 3, 1995 PCT Pub. No. WO95/26967 PCT Pub. Date Oct. 12, 1995The present invention relates to a novel process for the preparation of 7-trialkylsilylbaccatin III of general formula:    <IMAGE>  (I)  in which the symbols R, which may be identical or different, represent alkyl radicals containing 1 to 4 carbon atoms which are optionally substituted with a phenyl radical, starting with 10-deacetylbaccatin III of formula:    <IMAGE>  (II)  In the general formula (I), each of the symbols R preferably represents a straight or branched alkyl radical containing 1 to 4 carbon atoms. Even more particularly, each of the symbols R represents an ethyl radical.
Patent DE-69505493-T2 (DE)
Inventor: KLATZMANN DAVID
IPC: C12N15/87
Filed: 1995-02-22
Granted: 1999-04-22
Abstract: Host-vector system for expression of a transgene in a target cell or human/animal tissue comprises a eukaryotic cell line transfected with:(a) a recombinant psuedo-retroviral sequence in which all or part of the env gene has been deleted, either totally or partially, and replaced by the transgene as shown in figure 1a, and(b) a nucleic acid sequence which includes a sequence which codes for an envelope protein, is under the control of a promoter, is opt. associated with the transgene and is flanked on its 3' end by a polyadenylation site as shown in figure 1b; provided that(c) both (a) and (b) are capable of trans-complementation to permit the host cell to produce infectious env-deficient virus particles. Also claimed are:(1) a process for the expression of a transgene for gene therapy which comprises:(i) constructing a host-vector system as above;(ii) contacting the system with the cells in which the transgene is to be expressed, and(iii) opt. retransferring the env-contg. sequence into the target cells;(2) a process for the expression of a transgene for gene therapy which comprises the double transfection of target cells with:(i) env-deficient virus particles obtd. using the above host-vector system, and(ii) a nucleic acid sequence contg. a retroviral env gene; where(iii) trans co-expression of the 2 sequences in vivo results in infectious env-deficient recombinant virus particles;(3) a recombinant viral vector contg. a transgene useful in gene therapy, where:(i)a gene essential to the constitution of infectious virus particles is replaced by the transgene;(ii)the essential gene is present on the same or a different vector but is not under the control of viral promoters, and(iii) the prod. of the gene is trans-acting and permits reconstitution of defective virus particles;(4) a medication for use in gene therapy, contg. "vehicles" contg.:(i) a recombinant retroviral sequence in which the env gene is replaced by a trans gene, and(ii) a sequence contg. an env gene under the control of a promoter, where the env-contg. sequence is outside the zone of regulation of the expression of the retroviral sequences, and(5) a medication for use in gene therapy, contg. eukaryotic cells which have been subjected to double transfection and are "represented" by the above host-vector system.
Patent DE-69506085-T2 (DE)
Inventor: HAMMARLUND NILS
IPC: A61M11/02
Filed: 1995-01-19
Granted: 1999-06-17
Abstract: The invention relates to a method of converting a medicament to a form which can be used for administration to the airways or respiratory tracts of a mammal, wherein a liquid which consists in or includes a medicament is transformed to an aerosol which includes small liquid particles, with the aid of a gas stream or with the aid of other means, and wherein the liquid particles are collected in the gas stream or in a gas stream respectively, and wherein the liquid particles are collected in a gas which contains helium and/or neon and preferably also oxygen. The invention also relates to the use of a helium-containing and/or neon-containing gas mixture for producing an aerosol and a medicament preparation in the form of an aerosol consisting in liquid particles which are comprised of or include a medicament, and a gas mixture that contains helium and/or neon.
Patent DE-69506677-T2 (DE)
Inventor: LANSBERRY JOHN B
IPC: A01G23/097
Filed: 1995-10-18
Granted: 1999-09-09
Abstract: An apparatus (10) is provided for delimbing tree limbs of a felled tree including housing structure (16,18,20) constructed and arranged to be movable to a tree processing location. Support and feeding structure is constructed and arranged with respect to the housing structure (16,18,20) to support a stem portion of the tree while a limb thereof is severed and to move the stem portion progressively through the housing structure (16,18,20). Blade structure (34,38) is mounted on the housing structure and is constructed and arranged to move into engagement with a limb. Impact hammer structure (40) is operatively coupled to the blade structure (34,38) such that successive impacts generated by the impact hammer structure (40) on the blade structure move the blade structure progressively through a limb. Actuating structure (32) is operatively associated with the blade structure (34,38) and is constructed and arranged to move the blade structure (34,38) into engagement with a limb such that when the stem portion is supported by the support and feed structure and the blade structure is engaging the limb, the successive impacts generated by the impact hammer structure move the blade structure to sever the limb from the stem portion of the tree.
Patent DE-69508266-T2 (DE)
Inventor: HUARD MARCEL
IPC: G07F17/32
Filed: 1995-10-16
Granted: 1999-09-30
Abstract: An auxiliary game provides an auxiliary opportunity for players at a casino to win a prize by participating with a relatively small contribution each time they play a round in the principal casino game. To increase the element of random chance or luck in winning a prize in the game, a method and apparatus is provided for randomly choosing a winning card or combination of cards, or randomly selecting a person or group of persons eligible to win upon possession of the card or combination of cards. The amount of the prize can also be randomly selected either as a fixed amount or percentage of a maximum amount or a progressive jackpot.
Patent DE-69602630-T2 (DE)
Inventor: TAI SHINJI
IPC: C07C43/23
Filed: 1996-01-30
Granted: 1999-10-14
Abstract: A copolyester consisting essentially of ethylene terephthalate units and further comprising 0.01 to 1 mole % based on the sum of the moles of total diol units and the moles of triol units of a triol unit represented by the following formula (I) and/or a triol unit represented by the following formula (II). <CHEM>   <CHEM> wherein A is a group represented by formula -CH2CH2- or formula -CH(CH3)CH2-, B is a divalent hydrocarbon group, -CO-, -SO2-, -O- or a direct bond (-), and p, q, r, s, t and u are each an integer of 1 to 8. A process for producing the same and molded articles (in particular extrusion blow molded articles) therefrom. The copolyesters of the present invention are applicable to melt moldings accompanying melt extrusion, in particular extrusion blow molding, where parisons therefrom have good draw-down tendency and blow moldability. The copolyesters can give, without causing troubles on molding, molded articles, in particular extrusion blow molded articles, having excellent transparency, heat resistance, moisture resistance and like properties. Aromatic triols usable for producing the above copolyesters are also provided.
Patent DE-69606566-T2 (DE)
Inventor: BRYANT HENRY UHLMAN
IPC: A61K31/343
Filed: 1996-03-06
Granted: 2000-06-29
Abstract: Benzofuran derivs. of formula (I) and their salts are new: R1 = OH, halogen, 2-7C alkanoyloxy, aroyloxy, 4-6C alkylsulphonyloxy, (1-6C alkoxy)carbonyloxy, aryloxycarbonyloxy or mono- or di(1-6C alkyl)carbamoyloxy; R2 = aryl, 3-6C cycloalkyl or 4-hydroxycyclohexyl;l R3 = O(CH2)2 or O(CH2)3; R4, R5 = n-butyryl, n-valeryl or 1-6C alkyl, or NR4R5 = piperidino, morpholino, pyrrolidino, 3-methylpyrrolidino, 3,3-dimethylpyrrolidino, 3,4-dimethylpyrrolidino, azepino or pipecolino; R6 = C=CHR, CHR' or C(OH)R'; R = H or 1-5C alkyl and R' = 1-5C alkyl, 2-5C alkenyl or aryl.
Patent DE-69609146-T2 (DE)
Inventor: HONKALA MARKKU
IPC: A41D31/00
Filed: 1996-06-06
Granted: 2001-03-15
Abstract: PCT No. PCT/FI96/00336 Sec. 371 Date Feb. 5, 1997 Sec. 102(e) Date Feb. 5, 1997 PCT Filed Jun. 6, 1996 PCT Pub. No. WO96/39881 PCT Pub. Date Dec. 19, 1996An impact-resistant garment comprises closed rings (2) joined together to form a layer (1) protecting against impacts inside the garment. Elongate filling elements (3) of limited flexibility are threaded through the rings (2) to prevent the penetration of spike-shaped objects through the rings (2).
Patent DE-69613155-T2 (DE)
Inventor: VOGELAAR PIETER
IPC: B30B9/30
Filed: 1996-09-25
Granted: 2001-11-15
Abstract: The invention relates to a feed for domestic animals, consisting of dried and compressed long fibre material such as hay and straw, packaged in a foil, wherein the fibres are compressed into a volume enclosed by the foil, said material being compressed to a density which is higher than 90 kg/m<3> and includes one or more cutting faces (3) inwardly of the foil. The invention also includes a method and apparatus for making such feed.
Patent DE-69615849-T2 (DE)
Inventor: BRUEHMANN WOLFGANG FRIEDRICH W
IPC: F16D69/02
Filed: 1996-12-20
Granted: 2002-05-29
Abstract: Fitting for rotating drum or carrying conveyor belt comprises elastic material based on natural or synthetic rubber or polyurethane or equivalent in which is incorporated ceramic particles with dimensions between 10 and 2000 microns.
Patent DE-69622704-T2 (DE)
Inventor: MORAZZONI PAOLO
IPC: A61K31/12
Filed: 1996-05-08
Granted: 2003-04-03
Abstract: PCT No. PCT/EP96/01916 Sec. 371 Date Nov. 10, 1997 Sec. 102(e) Date Nov. 10, 1997 PCT Filed May 8, 1996 PCT Pub. No. WO96/35441 PCT Pub. Date Nov. 14, 1996The invention discloses to methods for preparing and using a lipophilic extract of the roots of Salvia miltiorrhyza Bunge for treating drug addiction. The Tanshinone IIA and Miltirone components of such lipophilic extracts are preferably used individually or in combination to treat drug addictions, and in particular, to treat alcohol addiction.
Patent DE-69622946-T2 (DE)
Inventor: SOLONEN JUHA
IPC: H04B7/26
Filed: 1996-03-01
Granted: 2003-05-08
Abstract: PCT No. PCT/FI96/00125 Sec. 371 Date Oct. 30, 1996 Sec. 102(e) Date Oct. 30, 1996 PCT Filed Mar. 1, 1996 PCT Pub. No. WO96/27955 PCT Pub. Date Sep. 12, 1996A method for synchronizing transmissions of mobile stations in a mobile radio system including a first and second mobile station and a radio unit all communicating on a direct mode channel. According to the method, the radio unit transmits synchronization information messages on the direct mode channel, which messages indicate the frequency used by the radio unit, and which messages include accuracy information, indicating that the accuracy of the transmit frequency used by the radio unit exceeds the accuracy normally employed on a direct mode channel. The mobile stations receive the synchronization information messages and tune respective receivers and transmitters to the frequencies indicated by the synchronization information message.
Patent DE-69637124-T2 (DE)
Inventor: KRIEGER MONTY
IPC: C12N15/12
Filed: 1996-11-15
Granted: 2008-02-07
Abstract: Methods for regulation of lipid and cholesterol uptake are described which are based on regulation of the expression or function of the SR-BI HDL receptor. The examples demonstrate that estrogen dramatically downregulates SR-BI under conditions of tremendous upregulation of the LDL-receptor. The examples also demonstrate the upregulation of SR-BI in rat adrenal membranes and other non-placental steroidogenic tissues from animals treated with estrogen, but not in other non-placental non-steroidogenic tissues, including lung, liver, and skin. Examples further demonstrate the uptake of fluorescently labeled HDL into the liver cells of animal, which does not occur when the animals are treated with estrogen.
Patent DE-69704920-T2 (DE)
Inventor: DYKHNO IGOR
IPC: H05H1/26
Filed: 1997-09-18
Granted: 2001-09-13
Abstract: A welding torch which combines features of both laser and plasma-arc welding torches. A laser beam (114) is directed by an objective lens (112) so that it is co-linear with the central axis (41) of a plasma-arc torch. The laser beam (114) passes through a planar or conical cathode electrode (116) placed at the bottom orifice of the torch. A coaxial aperture (117) having a diameter less than that of the laser beam is drilled into the cathode (116) to allow the laser beam to pass through the cathode. A constricting nozzle (130) placed under the cathode (116), with the laser beam passing through the axis of the nozzle. As with standard plasma-arc torch, a gas is forced through a chamber having the cathode (116) and nozzle (130) at its bottom end. As the cathode (116) is heated by the laser radiation, the gas is ionized and a plasma-arc is formed. As the laser beam passes through the nozzle (130), it comes to a focus and interacts with the plasma-arc formed between the cathode and a workpiece. The resulting interactions between the plasma-arc and laser beam form a plasma-laser discharge which acts to additionally constrict the laser beam and plasma-arc and increase the energy density of the welding spot formed on the workpiece. <IMAGE>
Patent DE-69706067-T2 (DE)
Inventor: CHIHANI THAMI
IPC: A61F13/49
Filed: 1997-11-26
Granted: 2002-03-21
Abstract: An absorbent article, such as a sanitary napkin, a panty-liner, or a diaper includes a carrier layer against which individual fibers, detached from each other and each exhibiting two fiber ends, are attached with one fiber end against the carrier layer. There is an attachment angle alpha between the carrier layer and each individual fiber. The individual fibers have at least a first fiber type and a second fiber type. The absorbent article further includes a liquid-pervious cover layer and a liquid acquisition layer.
Patent DE-69711691-T2 (DE)
Inventor: WILLIAMS NORMAN
IPC: H01L21/302
Filed: 1997-12-19
Granted: 2002-10-17
Abstract: An arrangement and method for matching a load and a power source, such as an r.f. power source for a vacuum plasma processing chamber, includes a match network coupled between the power source and the load. The match network has at least two controllably variable electrical characteristics. A sensor is provided that senses at least two parameters of the load. A drive controller responds to the sensed parameters of the load to independently control varying a first one of the electrical characteristics of the match network as a function of only one of the parameters of the load, and a second one of the electrical characteristics of the match network as a function of another one of the parameters of the load. This is done until the power source and the load are in a matched condition. The separation of the match variables to establish a nearly one-to-one correspondence with the load parameters allows independent adjustment of the match variables to provide fast and unambiguous reaching of the matched condition.
Patent DE-69713339-T2 (DE)
Inventor: ANDOU TUGUMITI
IPC: C09K19/04
Filed: 1997-03-27
Granted: 2002-12-05
Abstract: The invention is to provide liquid crystalline compounds which have a low viscosity, high negative dielectric anisotropy, high resistivity, and high voltage holding ratio, and are stable against heat and ultraviolet light; to provide liquid crystal compositions comprising the liquid crystalline compound; and to provide liquid crystal display devices using the liquid crystal composition therein;  the liquid crystalline compound is expressed by the general formula (1) <CHEM> wherein R<1> and Y<1> represent an alkyl group having 1 to 20 carbon atoms one or more non-adjacent methylene groups in the alkyl group may be replaced by oxygen atom, sulfur atom, or vinylene group; X<1>, X<2>, and X<3> independently represent single bond, 1,2-ethylene group, vinylene group, -COO-, provided that at least one of X<1>, X<2>, and X<3> represents -COO-, and one of the remaining two bonding groups necessarily represents vinylene group;  and wherein the rings A<1> to A<4> and m and n have the meanings as defined in claim 1.